Autonomix Medical to Showcase Transvascular Tech at CIRSE 2026
Event summary
- Two scientific abstracts accepted for poster presentation at CIRSE 2026 Annual Congress.
- Presentations focus on pain management in pancreatic adenocarcinoma and nervous system mapping.
- CIRSE 2026 takes place September 5-9, 2026, in Copenhagen, Denmark.
- Autonomix's transvascular technology aims to address complex nervous system challenges.
The big picture
Autonomix Medical's participation in CIRSE 2026 underscores the growing interest in minimally invasive, image-guided treatments for nervous system disorders. The company's transvascular technology positions it at the forefront of a shift toward precision nerve-targeted therapies, potentially disrupting traditional pain management and diagnostic approaches. The acceptance of its abstracts signals validation from the interventional radiology community, a critical step in scaling its platform across multiple indications.
What we're watching
- Clinical Validation
- How the poster presentations will impact the perception of Autonomix's technology among interventional radiologists.
- Market Expansion
- Whether Autonomix can leverage CIRSE 2026 to expand its reach beyond pain management into other indications.
- Regulatory Pathway
- The pace at which Autonomix can progress from investigational status to regulatory clearance for its platform technology.
Related topics